2022 Post Page

2022 Volume 4

Structured Benefit-Risk Assessments: An Illustrative Case Study of Paracetamol

Rosa A. Piccirillo and Jennifer Parish 2022/11/03 DOI: 10.36316/gcatr.04.0046. …
Read more

Pharmacovigilance Principles: The Building Blocks of Benefit-Risk Assessments

Rosa A. Piccirillo and Jennifer Parish 2022/10/14 DOI:10.36316/gcatr.04.0045. A medicinal product must demonstrate a favorable benefit-risk balance to remain on the market. That the benefits…
Read more